Explore more publications!
Health Update Bahamas
Got News to Share?

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 16, 2025

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100
December 16, 2025

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100

Indeterminate GlobeNewswire
Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
December 16, 2025

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer

Indeterminate GlobeNewswire
NetraMark and CAMH Announce Research Award to Advance AI-Driven Discovery in Schizophrenia and Depression
December 16, 2025

NetraMark and CAMH Announce Research Award to Advance AI-Driven Discovery in Schizophrenia and Depression

Indeterminate GlobeNewswire
PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors
December 16, 2025

PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors

Indeterminate GlobeNewswire
Chiesi Global Rare Diseases Announces Health Canada Approval of Elfabrio® (pegunigalsidase alfa) for Fabry Disease
December 16, 2025

Chiesi Global Rare Diseases Announces Health Canada Approval of Elfabrio® (pegunigalsidase alfa) for Fabry Disease

Indeterminate GlobeNewswire
Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025

Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
SRx Health Enters into Definitive Agreement to Acquire EMJX to Establish Next-Generation Digital Asset Treasury Operating System and Platform Led by Eric M. Jackson
December 16, 2025

SRx Health Enters into Definitive Agreement to Acquire EMJX to Establish Next-Generation Digital Asset Treasury Operating System and Platform Led by Eric M. Jackson

Indeterminate GlobeNewswire
December 2025 Letter to Shareholders
December 16, 2025

December 2025 Letter to Shareholders

Indeterminate GlobeNewswire
Nova Leap Health Corp. Launches Care Management Division In the United States
December 16, 2025

Nova Leap Health Corp. Launches Care Management Division In the United States

Indeterminate GlobeNewswire
MediBeacon® Next Generation TGFR™ System Receives FDA Approval
December 16, 2025

MediBeacon® Next Generation TGFR™ System Receives FDA Approval

Indeterminate GlobeNewswire
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
December 16, 2025

Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies

Indeterminate GlobeNewswire
Starton Therapeutics to Present at Biotech Showcase 2026
December 16, 2025

Starton Therapeutics to Present at Biotech Showcase 2026

Indeterminate GlobeNewswire
Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Enter into the Clinic
December 16, 2025

Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Enter into the Clinic

Indeterminate GlobeNewswire
Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America
December 16, 2025

Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America

Indeterminate GlobeNewswire
Elicio Therapeutics Reports Inducement Grants
December 16, 2025

Elicio Therapeutics Reports Inducement Grants

Indeterminate GlobeNewswire
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
December 16, 2025

Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)

Indeterminate GlobeNewswire
Marine Biologics Named a Top Food Technology Company for 2025 in Global Food Tech Awards
December 16, 2025

Marine Biologics Named a Top Food Technology Company for 2025 in Global Food Tech Awards

Indeterminate GlobeNewswire
Annovis to Host Corporate Update Webinar on January 28, 2026
December 16, 2025

Annovis to Host Corporate Update Webinar on January 28, 2026

Indeterminate GlobeNewswire
Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital
December 16, 2025

Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital

Indeterminate GlobeNewswire
MediBeacon® Next Generation TGFR™ System Receives FDA Approval
December 16, 2025

MediBeacon® Next Generation TGFR™ System Receives FDA Approval

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions